A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA).
A large anticancer armamentarium is available for treating patients with solid and hematological malignancies, but currently available therapies for cancer have many limitations in terms of curing the disease. Fighting for new therapies is thus essential, as is getting first-hand information on new therapies as they become available. The annual meeting of the American Society of Clinical Oncology (ASCO) helps serve that purpose by spreading knowledge on new treatments and new targets for intervention. To supplement ASCO's efforts and for the benefit of our users and readers, this report will offer a glimpse of what this year's meeting was like, giving special attention to currently available therapies and investigational drugs in development, the anticancer activity of which was reported during the meeting in Chicago.
Rabasseda
X
X
Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com
Gómez-Zaera
M
M
D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D007087:Illinois; D009369:Neoplasms / Q000188:drug therapy*